{"id":"https://openalex.org/W2014278172","doi":"https://doi.org/10.1182/blood-2004-07-2965","title":"Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy","display_name":"Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy","publication_year":2004,"publication_date":"2004-09-28","ids":{"openalex":"https://openalex.org/W2014278172","doi":"https://doi.org/10.1182/blood-2004-07-2965","mag":"2014278172","pmid":"https://pubmed.ncbi.nlm.nih.gov/15494422"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2004-07-2965","doi":"https://doi.org/10.1182/blood-2004-07-2965","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-07-2965","pdf_url":"https://ashpublications.org/blood/article-pdf/105/3/994/1705535/zh800305000994.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/105/3/994/1705535/zh800305000994.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086683313","display_name":"Michael C. Milone","orcid":"https://orcid.org/0000-0002-1580-9844","observed_orcids":["https://orcid.org/0000-0002-1580-9844"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210148193","display_name":"Hospital Brit\u00e1nico de Buenos Aires","ror":"https://ror.org/04djj4v98","country_code":"AR","type":"healthcare","lineage":["https://openalex.org/I4210148193"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["AR","US"],"is_corresponding":true,"raw_author_name":"M. C. Milone","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, Hematologic Malignancies Program, University of Pennsylvania, Philadelphia, USA","From the Department of Pathology and Laboratory Medicine and the Hematologic Malignancies Program, University of Pennsylvania","the Clinical Virology Laboratory and the Department of Pediatric Oncology, Children's Hospital of Philadelphia","the Department of Allergy and Immunology, Hospital Britanico, Buenos Aires, Argentina","the Department of Pediatric Hematology-Oncology, Children's Hospital, Boston MA","the Department of Pediatric Oncology, Dana-Farber Cancer Institute","the Departments of Pediatrics and Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, Hematologic Malignancies Program, University of Pennsylvania, Philadelphia, USA","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"From the Department of Pathology and Laboratory Medicine and the Hematologic Malignancies Program, University of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"the Clinical Virology Laboratory and the Department of Pediatric Oncology, Children's Hospital of Philadelphia","institution_ids":["https://openalex.org/I1335321130"]},{"raw_affiliation_string":"the Department of Allergy and Immunology, Hospital Britanico, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210148193"]},{"raw_affiliation_string":"the Department of Pediatric Hematology-Oncology, Children's Hospital, Boston MA","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"the Department of Pediatric Oncology, Dana-Farber Cancer Institute","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"the Departments of Pediatrics and Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5086683313"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1335321130","https://openalex.org/I4210117453","https://openalex.org/I4210148193","https://openalex.org/I79576946"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.6429,"has_fulltext":true,"cited_by_count":152,"citation_normalized_percentile":{"value":0.93370481,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"105","issue":"3","first_page":"994","last_page":"996"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.11599999666213989,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/x-linked-lymphoproliferative-disease","display_name":"X-linked lymphoproliferative disease","score":0.9800000190734863},{"id":"https://openalex.org/keywords/epstein-barr-virus-infection","display_name":"Epstein-Barr virus infection","score":0.9240000247955322},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9309999942779541},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.8870000243186951},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.9259999990463257},{"id":"https://openalex.org/keywords/primary-immunodeficiency","display_name":"primary immunodeficiency","score":0.7580000162124634},{"id":"https://openalex.org/keywords/preemptive-therapy","display_name":"preemptive therapy","score":0.7829999923706055},{"id":"https://openalex.org/keywords/lymphoma-prevention","display_name":"lymphoma prevention","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2776129502","wikidata":"https://www.wikidata.org/wiki/Q207367","display_name":"Mononucleosis","level":3,"score":0.7273960113525391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7036867141723633},{"id":"https://openalex.org/C2781107259","wikidata":"https://www.wikidata.org/wiki/Q5508364","display_name":"Fulminant","level":2,"score":0.7032609581947327},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.679218590259552},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6588848829269409},{"id":"https://openalex.org/C2781375147","wikidata":"https://www.wikidata.org/wiki/Q6900","display_name":"Epstein\u2013Barr virus","level":3,"score":0.5739141702651978},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5708315968513489},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5365097522735596},{"id":"https://openalex.org/C2776995267","wikidata":"https://www.wikidata.org/wiki/Q4165484","display_name":"Lymphoproliferative disorders","level":3,"score":0.5117754340171814},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4747267961502075},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4574207365512848},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.4384710192680359},{"id":"https://openalex.org/C2780494569","wikidata":"https://www.wikidata.org/wiki/Q5384031","display_name":"Epstein\u2013Barr virus infection","level":4,"score":0.4212995171546936},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3729473352432251},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.31238457560539246}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008232","descriptor_name":"Lymphoproliferative Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008232","descriptor_name":"Lymphoproliferative Disorders","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D041321","descriptor_name":"Chromosomes, Human, X","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1182/blood-2004-07-2965","doi":"https://doi.org/10.1182/blood-2004-07-2965","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-07-2965","pdf_url":"https://ashpublications.org/blood/article-pdf/105/3/994/1705535/zh800305000994.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:15494422","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15494422","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1182/blood-2004-07-2965","doi":"https://doi.org/10.1182/blood-2004-07-2965","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2004-07-2965","pdf_url":"https://ashpublications.org/blood/article-pdf/105/3/994/1705535/zh800305000994.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2014278172.pdf","grobid_xml":"https://content.openalex.org/works/W2014278172.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W48884","https://openalex.org/W148064955","https://openalex.org/W1487843912","https://openalex.org/W1510178802","https://openalex.org/W1596464911","https://openalex.org/W1981485037","https://openalex.org/W1981854978","https://openalex.org/W1982969435","https://openalex.org/W1984588501","https://openalex.org/W1985739029","https://openalex.org/W1987696799","https://openalex.org/W2022597658","https://openalex.org/W2056059306","https://openalex.org/W2065684619","https://openalex.org/W2098626256","https://openalex.org/W2103155822","https://openalex.org/W2112476236","https://openalex.org/W2119445283","https://openalex.org/W2133864160","https://openalex.org/W2156324671","https://openalex.org/W2158786091","https://openalex.org/W2170419443","https://openalex.org/W4285719527","https://openalex.org/W6645011121"],"related_works":["https://openalex.org/W2170494925","https://openalex.org/W4386981683","https://openalex.org/W4409786579","https://openalex.org/W2329057176","https://openalex.org/W2021700348","https://openalex.org/W2118164035","https://openalex.org/W2805926678","https://openalex.org/W148064955","https://openalex.org/W2147415511","https://openalex.org/W2489519891"],"abstract_inverted_index":{"X-linked":[0],"lymphoproliferative":[1],"disease":[2],"(XLP)":[3],"is":[4,9],"a":[5,33,98],"congenital":[6],"immunodeficiency":[7],"that":[8,52,131],"characterized":[10],"by":[11,37],"an":[12],"abnormal":[13],"immune":[14],"response":[15],"to":[16,85],"primary":[17,68,145],"Epstein-Barr":[18],"virus":[19],"(EBV)":[20],"infection.":[21,92],"After":[22],"EBV":[23,61,69,108,146],"exposure,":[24],"affected":[25],"patients":[26,72,87,96],"often":[27],"develop":[28],"fulminant":[29],"infectious":[30],"mononucleosis":[31],"(FIM),":[32],"life-threatening":[34],"condition":[35],"marked":[36],"the":[38,53,65,81,132,140],"uncontrolled":[39],"expansion":[40],"and":[41,45,48,103,142],"activation":[42],"of":[43,56,67,101,126,135,144],"T":[44],"B":[46,57],"lymphocytes":[47],"macrophages.":[49],"We":[50],"hypothesized":[51],"rapid":[54],"elimination":[55],"cells":[58],"immediately":[59],"following":[60],"exposure":[62],"might":[63],"reduce":[64,139],"severity":[66],"infection":[70,147],"in":[71,121,148],"with":[73,90],"XLP.":[74],"To":[75],"test":[76],"this":[77],"possibility,":[78],"we":[79],"administered":[80],"anti-CD20":[82],"antibody":[83],"rituximab":[84],"2":[86,124],"who":[88],"presented":[89],"acute":[91],"Following":[93],"treatment,":[94],"both":[95],"exhibited":[97],"complete":[99],"resolution":[100],"symptoms":[102],"no":[104],"longer":[105],"demonstrated":[106],"detectable":[107],"DNA":[109],"within":[110],"circulating":[111],"lymphocytes.":[112],"Moreover,":[113],"neither":[114],"patient":[115],"has":[116],"developed":[117],"FIM":[118],"or":[119],"lymphoma":[120],"more":[122],"than":[123],"years":[125],"follow-up.":[127],"These":[128],"data":[129],"suggest":[130],"pre-emptive":[133],"use":[134],"B-cell-directed":[136],"therapy":[137],"may":[138],"morbidity":[141],"mortality":[143],"XLP-affected":[149],"individuals.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}